AMIZYME EPSTEIN-BARR VIRUS (EBV) IGM ANTIBODY TEST— 510(k) K911362

Substantially Equivalent

Amico Laboratories, Inc.

FDA 510(k) clearance K911362 for AMIZYME EPSTEIN-BARR VIRUS (EBV) IGM ANTIBODY TEST, Substantially Equivalent on 1991-10-07. Applicant: Amico Laboratories, Inc..

Clearance details

Applicant
Amico Laboratories, Inc.
Product code
Code LJN
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Nashville, TN, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.